vs

Side-by-side financial comparison of APTARGROUP, INC. (ATR) and Iron Mountain (IRM). Click either name above to swap in a different company.

Iron Mountain is the larger business by last-quarter revenue ($1.8B vs $962.7M, roughly 1.9× APTARGROUP, INC.). APTARGROUP, INC. runs the higher net margin — 7.7% vs 5.1%, a 2.7% gap on every dollar of revenue. On growth, Iron Mountain posted the faster year-over-year revenue change (16.6% vs 13.5%). APTARGROUP, INC. produced more free cash flow last quarter ($96.9M vs $-16.2M). Over the past eight quarters, Iron Mountain's revenue compounded faster (11.7% CAGR vs 2.6%).

AptarGroup, Inc., also known as Aptar, is a United States–based global manufacturer of consumer dispensing packaging and drug delivery devices. The group has manufacturing operations in 18 countries.

Iron Mountain Inc. is an American enterprise information management services company founded in 1951 and headquartered in Portsmouth, New Hampshire. Its records management, information destruction, and data backup and recovery services are supplied to more than 220,000 customers in 58 countries throughout North America, Europe, Latin America, Africa, Asia, and Oceania.

ATR vs IRM — Head-to-Head

Bigger by revenue
IRM
IRM
1.9× larger
IRM
$1.8B
$962.7M
ATR
Growing faster (revenue YoY)
IRM
IRM
+3.0% gap
IRM
16.6%
13.5%
ATR
Higher net margin
ATR
ATR
2.7% more per $
ATR
7.7%
5.1%
IRM
More free cash flow
ATR
ATR
$113.1M more FCF
ATR
$96.9M
$-16.2M
IRM
Faster 2-yr revenue CAGR
IRM
IRM
Annualised
IRM
11.7%
2.6%
ATR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ATR
ATR
IRM
IRM
Revenue
$962.7M
$1.8B
Net Profit
$74.3M
$93.1M
Gross Margin
Operating Margin
11.0%
18.5%
Net Margin
7.7%
5.1%
Revenue YoY
13.5%
16.6%
Net Profit YoY
-26.4%
-11.9%
EPS (diluted)
$1.13
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ATR
ATR
IRM
IRM
Q4 25
$962.7M
$1.8B
Q3 25
$961.1M
$1.8B
Q2 25
$966.0M
$1.7B
Q1 25
$887.3M
$1.6B
Q4 24
$848.1M
$1.6B
Q3 24
$909.3M
$1.6B
Q2 24
$910.1M
$1.5B
Q1 24
$915.4M
$1.5B
Net Profit
ATR
ATR
IRM
IRM
Q4 25
$74.3M
$93.1M
Q3 25
$127.9M
$86.2M
Q2 25
$111.7M
$-43.3M
Q1 25
$78.8M
$16.2M
Q4 24
$100.9M
$105.7M
Q3 24
$100.0M
$-33.7M
Q2 24
$90.5M
$34.6M
Q1 24
$83.1M
$77.0M
Operating Margin
ATR
ATR
IRM
IRM
Q4 25
11.0%
18.5%
Q3 25
14.2%
17.6%
Q2 25
14.9%
15.2%
Q1 25
12.8%
16.0%
Q4 24
14.2%
17.9%
Q3 24
15.2%
16.1%
Q2 24
13.8%
15.0%
Q1 24
12.2%
16.6%
Net Margin
ATR
ATR
IRM
IRM
Q4 25
7.7%
5.1%
Q3 25
13.3%
4.9%
Q2 25
11.6%
-2.5%
Q1 25
8.9%
1.0%
Q4 24
11.9%
6.7%
Q3 24
11.0%
-2.2%
Q2 24
9.9%
2.3%
Q1 24
9.1%
5.2%
EPS (diluted)
ATR
ATR
IRM
IRM
Q4 25
$1.13
$0.31
Q3 25
$1.92
$0.28
Q2 25
$1.67
$-0.15
Q1 25
$1.17
$0.05
Q4 24
$1.48
$0.35
Q3 24
$1.48
$-0.11
Q2 24
$1.34
$0.12
Q1 24
$1.23
$0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ATR
ATR
IRM
IRM
Cash + ST InvestmentsLiquidity on hand
$409.5M
$158.5M
Total DebtLower is stronger
$1.1B
$16.2B
Stockholders' EquityBook value
$2.7B
$-981.0M
Total Assets
$5.3B
$21.1B
Debt / EquityLower = less leverage
0.43×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ATR
ATR
IRM
IRM
Q4 25
$409.5M
$158.5M
Q3 25
$264.8M
Q2 25
$169.8M
Q1 25
$136.8M
Q4 24
$226.2M
$155.7M
Q3 24
$327.9M
Q2 24
$223.9M
Q1 24
$201.1M
Total Debt
ATR
ATR
IRM
IRM
Q4 25
$1.1B
$16.2B
Q3 25
$546.0M
$15.5B
Q2 25
$535.1M
$14.8B
Q1 25
$561.2M
$14.2B
Q4 24
$688.1M
$13.0B
Q3 24
$822.7M
$13.2B
Q2 24
$681.5M
$12.8B
Q1 24
$680.4M
$12.6B
Stockholders' Equity
ATR
ATR
IRM
IRM
Q4 25
$2.7B
$-981.0M
Q3 25
$2.8B
$-882.0M
Q2 25
$2.7B
$-767.4M
Q1 25
$2.5B
$-698.5M
Q4 24
$2.5B
$-503.1M
Q3 24
$2.5B
$-259.0M
Q2 24
$2.4B
$-132.9M
Q1 24
$2.3B
$18.5M
Total Assets
ATR
ATR
IRM
IRM
Q4 25
$5.3B
$21.1B
Q3 25
$5.1B
$20.6B
Q2 25
$4.9B
$20.2B
Q1 25
$4.5B
$19.4B
Q4 24
$4.4B
$18.7B
Q3 24
$4.6B
$18.5B
Q2 24
$4.5B
$18.0B
Q1 24
$4.4B
$17.8B
Debt / Equity
ATR
ATR
IRM
IRM
Q4 25
0.43×
Q3 25
0.20×
Q2 25
0.20×
Q1 25
0.22×
Q4 24
0.28×
Q3 24
0.32×
Q2 24
0.28×
Q1 24
0.29×
679.18×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ATR
ATR
IRM
IRM
Operating Cash FlowLast quarter
$183.7M
$500.0M
Free Cash FlowOCF − Capex
$96.9M
$-16.2M
FCF MarginFCF / Revenue
10.1%
-0.9%
Capex IntensityCapex / Revenue
9.0%
28.0%
Cash ConversionOCF / Net Profit
2.47×
5.37×
TTM Free Cash FlowTrailing 4 quarters
$299.6M
$-931.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ATR
ATR
IRM
IRM
Q4 25
$183.7M
$500.0M
Q3 25
$177.6M
$267.6M
Q2 25
$126.0M
$375.1M
Q1 25
$82.7M
$197.3M
Q4 24
$178.2M
$431.6M
Q3 24
$229.3M
$252.9M
Q2 24
$143.6M
$382.2M
Q1 24
$92.3M
$130.0M
Free Cash Flow
ATR
ATR
IRM
IRM
Q4 25
$96.9M
$-16.2M
Q3 25
$114.3M
$-256.3M
Q2 25
$62.5M
$-181.6M
Q1 25
$25.9M
$-477.5M
Q4 24
$112.2M
$-186.0M
Q3 24
$162.7M
$-143.2M
Q2 24
$75.4M
$-14.6M
Q1 24
$16.7M
$-251.1M
FCF Margin
ATR
ATR
IRM
IRM
Q4 25
10.1%
-0.9%
Q3 25
11.9%
-14.6%
Q2 25
6.5%
-10.6%
Q1 25
2.9%
-30.0%
Q4 24
13.2%
-11.8%
Q3 24
17.9%
-9.2%
Q2 24
8.3%
-1.0%
Q1 24
1.8%
-17.0%
Capex Intensity
ATR
ATR
IRM
IRM
Q4 25
9.0%
28.0%
Q3 25
6.6%
29.9%
Q2 25
6.6%
32.5%
Q1 25
6.4%
42.4%
Q4 24
7.8%
39.1%
Q3 24
7.3%
25.4%
Q2 24
7.5%
25.9%
Q1 24
8.3%
25.8%
Cash Conversion
ATR
ATR
IRM
IRM
Q4 25
2.47×
5.37×
Q3 25
1.39×
3.10×
Q2 25
1.13×
Q1 25
1.05×
12.15×
Q4 24
1.77×
4.08×
Q3 24
2.29×
Q2 24
1.59×
11.04×
Q1 24
1.11×
1.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ATR
ATR

Pharma Segment$833.1M87%
Other$129.6M13%

IRM
IRM

Storage Rental$1.1B58%
Services$781.9M42%

Related Comparisons